Last reviewed · How we verify

NCT03565796

Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2018

Completed NA Last updated 21 September 2021
What this trial tests

NA trial testing Personalized active referral plus financial incentive in Smoking Cessation in 1,093 participants. Completed in 30 June 2020.

Timeline
16 June 2018
Primary endpoint
30 June 2019
30 June 2020

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment1,093
Start date16 June 2018
Primary completion30 June 2019
Estimated completion30 June 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will examine (1) the effectiveness of a combined intervention of face-to-face brief cessation advice (AWARD), active referral of SC service plus financial incentive on encouraging SC services use and (2) explore the use of CBPR model to build capacity and to engage community partners in taking on this important public health issue for sustainability in the community. In addition, a process evaluation will be conducted to assess the effectiveness of the recruitment activity and how it is linked with the overall program outcomes.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Association of heated tobacco product use with smoking cessation in Chinese cigarette smokers in Hong Kong: a prospective study.
    Luk TT, Weng X, Wu YS, Chan HL, et al · · 2021 · cited 16× · PMID 32912861 · DOI 10.1136/tobaccocontrol-2020-055857
  2. Active referral plus a small financial incentive upon cessation services use on smoking abstinence: a community-based, cluster-randomised controlled trial.
    Weng X, Wu Y, Luk TT, Li WHC, et al · · 2021 · cited 15× · PMID 34527982 · DOI 10.1016/j.lanwpc.2021.100189
  3. High Perceived Susceptibility to and Severity of COVID-19 in Smokers Are Associated with Quitting-Related Behaviors.
    Li Y, Luk TT, Wu Y, Cheung DYT, et al · · 2021 · cited 11× · PMID 34682641 · DOI 10.3390/ijerph182010894
  4. Associations of changes in smoking-related practices with quit attempt and smoking consumption during the COVID-19 pandemic: A mixed-methods study.
    Zeng Y, Luk TT, Wu YS, Tong SCΗ, et al · · 2022 · cited 3× · PMID 36588925 · DOI 10.18332/tid/156454
  5. Effects of active referral combined with a small financial incentive on smoking cessation: study protocol for a cluster randomised controlled trial.
    Weng X, Wang MP, Li HCW, Cheung YTD, et al · · 2020 · cited 3× · PMID 33109654 · DOI 10.1136/bmjopen-2020-038351

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03565796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing